Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Indian Bank may test Rs 260, Lakshmi Vilas Bank Rs 185: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that Indian Bank may test Rs 260 and Lakshmi Vilas Bank may hit Rs 185.

    • Here are a few stocks ideas from SP Tulsian

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.

    • Sell Aurobindo Pharma; buy HeidelbergCement, UltraTech: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Aurobindo Pharma and buy HeidelbergCement and UltraTech Cement.

    • Investment tips: 6 bumper stocks that analysts are focusing on

      Credit Suisse maintains underperform rating on Idea with target price at Rs 80 per share. It feels merger with Vodafone merger will not be an easy one as both companies are highly leveraged. It adds that any potential merger will have to wait for auction to complete.

    • Stay invested in Aurobindo Pharma: Sharmila Joshi

      According to Sharmila Joshi of sharmilajoshi.com, one may stay invested in Aurobindo Pharma.

    • Prefer Biocon over Aurobindo Pharma: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may prefer Biocon over Aurobindo Pharma.

    • Here are a few stock ideas from Prakash Diwan

      In an interview to CNBC-TV18, Prakash Diwan of prakashdiwan.in shared his readings and outlook on specific stocks and sector.

    • Buy Escorts, Dishman Pharma; sell Lupin, Auro Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Escorts and Dishman Pharma andadvises selling Lupin, Granules India and Aurobindo Pharma.

    • Six in Sixty: Stocks you should keep on your radar

      CNBC-TV18's Ekta Batra lists six stocks that you should focus on - Infosys, Sun Pharmaceuticals, Lupin, Aurobindo Pharma, Bank Nifty, BHEL, HPCL, and Welspun India.

    • By BPCL, Aurobindo Pharma; sell Mindtree: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Bharat Petroleum Corporation and Aurobindo Pharma and advises selling Mindtree.

    • Buy Divis Labs, Power Grid; sell Aurobindo Pharma: Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can buy Divis Labs and Power Grid and sell Aurobindo Pharma.

    • Short Pidilite, Aurobindo Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends shorting Pidilite Industries and Aurobindo Pharma and feels that Jubilant Foodworks may head lower.

    • Sell Aurobindo Pharma, Oil India; buy HCL Tech: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com recommends selling Aurobindo Pharma and Oil India and advises buying HCL Technologies.

    • Exit Aurobindo Pharma close to Rs 790, says Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one may exit Aurobindo Pharma close to Rs 790.

    • Pending order pipeline, turnaround in US key for Aurobindo:BoAML

      Bank of America Merrill Lynch (BoAML), in a report, says that concerns over contraction in its US business and reduction in Research & Development are main concerns for investors. Also, pursuance of expensive Mergers & Acquisitions and inferior cash conversion abilities continue to weigh on Aurobindo.

    • Buy MRF; sell Aurobindo Pharma: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, oen can buy MRF and sell Aurobindo Pharma.

    • Buy Aurobindo Pharma, Hindustan Zinc, Voltas: Ashish Kyal

      Ashish Kyal of wavesstrategy.com is of the view that one can buy Aurobindo Pharma, Hindustan Zinc and Voltas.

    • Here are a few stock ideas from Ajay Bodke

      In an interview to CNBC-TV18, Ajay Bodke, CEO & Chief Portfolio Manager (PMS) at Prabhudas Lilladher Pvt. Ltd shared his readings and outlook on market, specific stocks and sectors.

    • Checkout: SP Tulsian's views on Dish TV, Alembic Pharma, sugar

      SP Tulsian, sptulsian.com in an interview to CNBC-TV18 shared his views on stocks like Dish TV, Alembic pharma, sugar stocks, SPARC, Sundaram Finance and others

    • Bull's Eye: Buy Havells, Biocon, Apollo Tyres, Aurobindo Pharma

      Vijay Chopra of enochventures.com advises buying Chennai Petro with a target of Rs 265.

    • Aurobindo Pharma top pick: Dhananjay Sinha

      According to Dhananjay Sinha of Emkay Global Financial Services, Aurobindo Pharma is a top pick.

    • Aurobindo Pharma may hit Rs 825: Prakash Gaba

      Accordiing to Prakash Gaba of prakashgaba.com, Aurobindo Pharma may hit Rs 825.

    • Buy Aurobindo Pharma; hold JSW Energy: Ashish Chaturmohta

      Ashish Chaturmohta of Sanctum Wealth Management is of the view that one can buy Aurobindo Pharma and Divis Labs and hold JSW Energy.

    • Buy Wockhardt, Aurobindo Pharma: CA Rudramurthy BV

      CA Rudramurthy BV of Vachana Investments recommends buying Wockhardt and Aurobindo Pharma.

    • Optimistic on logistics; like Aurobindo & DRL: Mayuresh Joshi

      In an interview to CNBC-TV18 Mayuresh Joshi of Angel Broking shared his reading and outlook on the market as well as on various stocks and sectors.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347